STOCK TITAN

MariMed Announces Fourth Quarter and Full Year 2023 Earnings Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
MariMed Inc. will report its Q4 and full year 2023 financial results on March 6, 2024, followed by a conference call on March 7, 2024. The company aims to discuss its financial performance and provide a webcast for investors.
Positive
  • None.
Negative
  • None.

NORWOOD, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today it will report fourth quarter and full year 2023 financial results on March 6, 2024 after the markets close. Management will host a conference call on March 7, 2024 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q423 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, InHouse™, Bubby’s Baked™, K Fusion™, Kalm Fusion™, and Vibations™. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


MariMed Inc. will report its Q4 and full year 2023 financial results on March 6, 2024.

The conference call to discuss MariMed Inc.'s financial results will be held on March 7, 2024 at 8:00 a.m. EST.

Investors can access the webcast via MariMed’s Investor Relations website at MariMed Q423 Earnings Webcast.

The playback of the call will be made available on MariMed’s Investor Relations website.
MariMed Inc

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Packaged Software, Technology Services, Process Industries, Agricultural Commodities/Milling, Information, Data Processing, Hosting, and Related Services